These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15025850)

  • 21. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
    Oskouei DS; Rikhtegar R; Hashemilar M; Sadeghi-Bazargani H; Sharifi-Bonab M; Sadeghi-Hokmabadi E; Zarrintan S; Sharifipour E
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e557-63. PubMed ID: 23871729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental approach of treatment of cerebral ischemia by a combination of raubasine and almitrine.
    Borzeix MG; Cahn J
    Arzneimittelforschung; 1987 May; 37(5):491-4. PubMed ID: 2887170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of almitrine and raubasine, singly and in combination, on electroencephalographic activity in young and old rats.
    Sebban C; Tesolin B; Coulomb B; Berthaux P
    Exp Gerontol; 1989; 24(1):11-24. PubMed ID: 2707311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of 5023 SE on PaO2 at rest in elderly patients with cerebral impairment. A double-blind cross-over trial versus placebo].
    Memin Y
    Presse Med; 1983 Mar; 12(13):849-51. PubMed ID: 6220335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological approach to a treatment of senescence and cerebrovascular deficiencies related to hypoxia. Application to 5023 SE].
    Devissaguet M
    Presse Med; 1983 Mar; 12(13):823-9. PubMed ID: 6220330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlling hypertension and hypotension immediately post stroke (CHHIPS)--a randomised controlled trial.
    Potter J; Mistri A; Brodie F; Chernova J; Wilson E; Jagger C; James M; Ford G; Robinson T
    Health Technol Assess; 2009 Jan; 13(9):iii, ix-xi, 1-73. PubMed ID: 19208305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) and fluoxetine on post-stroke depression.
    Li LT; Wang SH; Ge HY; Chen J; Yue SW; Yu M
    J Altern Complement Med; 2008 Sep; 14(7):841-6. PubMed ID: 18721085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of almitrine/raubasine on cerebral metabolism in the elderly].
    Allain H; Bentué-Ferrer D
    Presse Med; 2002 Mar; 31(12):562-4. PubMed ID: 11984975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Demonstration of the therapeutic activity of 5023 SE on intellectual and psychomotor efficacy in elderly impaired patients. Double-blind controlled study versus placebo].
    Berthaux P; Laforestrie R
    Presse Med; 1983 Mar; 12(13):852-5. PubMed ID: 6220336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CHInese Medicine NeuroAiD Efficacy on Stroke Recovery - Extension Study (CHIMES-E): A Multicenter Study of Long-Term Efficacy.
    Venketasubramanian N; Young SH; Tay SS; Umapathi T; Lao AY; Gan HH; Baroque AC; Navarro JC; Chang HM; Advincula JM; Muengtaweepongsa S; Chan BP; Chua CL; Wijekoon N; de Silva HA; Hiyadan JH; Suwanwela NC; Wong KS; Poungvarin N; Eow GB; Lee CF; Chen CL;
    Cerebrovasc Dis; 2015; 39(5-6):309-18. PubMed ID: 25925713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute and chronic effects of low dose almitrine bismesylate in the treatment of chronic bronchitis and emphysema.
    Winkelmann BR; Leinberger H; Hertrich FF; Rapp W; Dieterich HA; Ansquer JC
    Eur J Med; 1992 Dec; 1(8):469-81. PubMed ID: 1341206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability-indicating methods for the determination of a mixture of almitrine and raubasine by derivative spectrophotometry.
    El-Sayed MA
    Drug Test Anal; 2009 Jun; 1(6):279-85. PubMed ID: 20355207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. European and Australian Lubeluzole Ischaemic Stroke Study Group.
    Diener HC
    Cerebrovasc Dis; 1998; 8(3):172-81. PubMed ID: 9619701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CHIMES-I: sub-group analyzes of the effects of NeuroAiD according to baseline brain imaging characteristics among patients randomized in the CHIMES study.
    Navarro JC; Chen CL; Lagamayo PD; Geslani MB; Eow GB; Poungvarin N; de Silva A; Wong LK; Venketasubramanian N;
    Int J Stroke; 2013 Aug; 8(6):491-4. PubMed ID: 23506216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Durability of the beneficial effect of MLC601 (NeuroAiD™) on functional recovery among stroke patients from the Philippines in the CHIMES and CHIMES-E studies.
    Navarro JC; Chen CL; Lee CF; Gan HH; Lao AY; Baroque AC; Hiyadan JH; Chua CL; San Jose MC; Advincula JM; Venketasubramanian N;
    Int J Stroke; 2017 Apr; 12(3):285-291. PubMed ID: 27784824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial.
    Ladurner G; Kalvach P; Moessler H;
    J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral ischemia: from pharmacology to modern techniques and clinical implications. Value of almitrine-raubasin (Duxil Duxaril). International symposium, Hangzhou, People's Republic of China, May 14, 1994.
    Eur Neurol; 1995; 35 Suppl 1():1-46. PubMed ID: 8529722
    [No Abstract]   [Full Text] [Related]  

  • 38. Glycine antagonist (GV150526) in acute stroke: a multicentre, double-blind placebo-controlled phase II trial.
    Lees KR; Lavelle JF; Cunha L; Diener HC; Sanders EA; Tack P; Wester P;
    Cerebrovasc Dis; 2001; 11(1):20-9. PubMed ID: 11173790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurologic and histologic evaluation of almitrine+raubasine (Duxil) in middle cerebral artery occlusion in cats.
    Chan P; Li Y; Zheng Z; Hu P; Sarbach SD; Guez D
    Eur J Pharmacol; 1993 Feb; 231(2):175-82. PubMed ID: 8453973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Duxil and cognitive deficiency in the elderly. Results of a 6-month controlled multicenter study].
    Poitrenaud J; Piette F; Malbezin M; Sebban C; Guez D
    Ann Med Interne (Paris); 1990; 141 Suppl 1():31-5. PubMed ID: 2082783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.